At a molecular level, FGF2 binds to multiple membrane bound receptors in human cancers, including SDC1 [39], and this receptor binding can trigger multiple signaling pathways, including those involved in cell proliferation and survival [40,41]. This evidence concerns the gene SDC1 and cancer.